| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2000;70:358-365
© 2000 The Society of Thoracic Surgeons
a Department of Surgery, The Beth Israel Medical Center, New York, New York, USA
b Department of Biostatistics, Dana Farber Cancer Institute, Boston, Massachusetts, USA
c Department of Radiation Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA
d Department of Medical Oncology, Vanderbilt University, Nashville, Tennessee, USA
e Coordinating Center, Brookline, Massachusetts, USA
Address reprint requests to Dr Keller, Department of Surgery, Beth Israel Medical Center, First Ave and 16th St, New York, NY 10003;
e-mail: skeller{at}bethisraelny.org
Presented at the Thirty-sixth Annual Meeting of The Society of Thoracic Surgeons, Ft. Lauderdale, FL, Jan 31–Feb 2, 2000.
Abstract
Background. Mediastinal lymph node dissection (MLND) is an integral part of surgery for non-small cell lung cancer (NSCLC). To compare the impact of systematic sampling (SS) and complete MLND on the identification of mediastinal lymph node metastases and patient survival, the Eastern Cooperative Oncology Group (ECOG) stratified patients by type of MLND before participation in ECOG 3590 (a randomized prospective trial of adjuvant therapy in patients with completely resected stages II and IIIa NSCLC).
Methods. Eligibility requirements for study entry included a thorough investigation of the mediastinal lymph nodes with either SS or complete MLND. The former was defined as removal of at least one lymph node at levels 4, 7, and 10 during a right thoracotomy and at levels 5 and/or 6 and 7 during a left thoracotomy, while the latter required complete removal of all lymph nodes at those levels.
Results. Three hundred seventy-three eligible patients were accrued to the study. Among the 187 patients who underwent SS, N1 disease was identified in 40% and N2 disease in 60%. This was not significantly different than the 41% of N1 disease and 59% of N2 disease found among the 186 patients who underwent complete MLND. Among the 222 patients with N2 metastases, multiple levels of N2 disease were documented in 30% of patients who underwent complete MLND and in 12% of patients who had SS (p = 0.001). Median survival was 57.5 months for those patients who had undergone complete MLND and 29.2 months for those patients who had SS (p = 0.004). However, the survival advantage was limited to patients with right lung tumors (66.4 months vs 24.5 months, p < 0.001).
Conclusions. In this nonrandomized comparison, SS was as efficacious as complete MLND in staging patients with NSCLC. However, complete MLND identified significantly more levels of N2 disease. Furthermore, complete MLND was associated with improved survival with right NSCLC when compared with SS.
Related Article
Ann. Thorac. Surg. 2000 70: 365-366.
This article has been cited by other articles:
|
|
 |
|
  A. F. Verhagen, M. C. J. Schoenmakers, W. Barendregt, H. Smit, W.-J. van Boven, M. Looijen, E. H. F. M. van der Heijden, and H. A. van Swieten Completeness of lung cancer surgery: is mediastinal dissection common practice? Eur J Cardiothorac Surg, January 18, 2012; (2012) ezr059v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Schirren, M. Eberlein, A. Fischer, and S. Bolukbas The role of sleeve resections in advanced nodal disease Eur J Cardiothorac Surg, November 1, 2011; 40(5): 1157 - 1164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Hughes, M. F. Chowdhry, S. M. Woolley, and W. S. Walker In patients undergoing lung resection for non-small cell lung cancer, is lymph node dissection or sampling superior? Interact CardioVasc Thorac Surg, September 1, 2011; 13(3): 311 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. D'Amico, J. Niland, R. Mamet, C. Zornosa, E. U. Dexter, and M. W. Onaitis Efficacy of Mediastinal Lymph Node Dissection During Lobectomy for Lung Cancer by Thoracoscopy and Thoracotomy Ann. Thorac. Surg., July 1, 2011; 92(1): 226 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Toker, S. Tanju, S. Ziyade, S. Kaya, S. Erus, B. Ozkan, and D. Yilmazbayhan Alternative paratracheal lymph node dissection in left-sided hilar lung cancer patients: comparing the number of lymph nodes dissected to the number of lymph nodes dissected in right-sided mediastinal dissections Eur J Cardiothorac Surg, June 1, 2011; 39(6): 974 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. U. Osarogiagbon, J. W. Allen, A. Farooq, A. Berry, and T. O'Brien Pathologic Lymph Node Staging Practice and Stage-Predicted Survival After Resection of Lung Cancer Ann. Thorac. Surg., May 1, 2011; 91(5): 1486 - 1492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Darling, M. S. Allen, P. A. Decker, K. Ballman, R. A. Malthaner, R. I. Inculet, D. R. Jones, R. J. McKenna, R. J. Landreneau, and J. B. Putnam Jr Number of Lymph Nodes Harvested From a Mediastinal Lymphadenectomy: Results of the Randomized, Prospective American College of Surgeons Oncology Group Z0030 Trial Chest, May 1, 2011; 139(5): 1124 - 1129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Le Pechoux Role of Postoperative Radiotherapy in Resected Non-Small Cell Lung Cancer: A Reassessment Based on New Data Oncologist, May 1, 2011; 16(5): 672 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Darling, M. S. Allen, P. A. Decker, K. Ballman, R. A. Malthaner, R. I. Inculet, D. R. Jones, R. J. McKenna, R. J. Landreneau, V. W. Rusch, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial. J. Thorac. Cardiovasc. Surg., March 1, 2011; 141(3): 662 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Saynak, J. Hubbs, J. Nam, L. B. Marks, R. H. Feins, B. E. Haithcock, and N. K. Veeramachaneni Variability in Defining T1N0 Non-Small Cell Lung Cancer Impacts Locoregional Failure and Survival Ann. Thorac. Surg., November 1, 2010; 90(5): 1645 - 1650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Di Maria, L. Spicuzza, and R. Polosa Antibiotics and new guidelines for the treatment of lower respiratory tract infections Thoracic Malignancies, June 28, 2010; 175 - 188. [Abstract] [Fulltext] [PDF]
|
|
|
|
|
|
T. Szoke, A. Kortner, R. Neu, C. Grosser, Z. Sziklavari, K. Wiebe, and H.-S. Hofmann Is the mediastinal lymphadenectomy during pulmonary metastasectomy of colorectal cancer necessary? Interact CardioVasc Thorac Surg, May 1, 2010; 10(5): 694 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ishiguro, K. Matsuo, T. Fukui, S. Mori, S. Hatooka, and T. Mitsudomi Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: A large-scale retrospective cohort study applying a propensity score J. Thorac. Cardiovasc. Surg., April 1, 2010; 139(4): 1001 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bolukbas, T. Bergmann, A. Fisseler-Eckhoff, and J. Schirren Short- and long-term outcome of sleeve resections in the elderly Eur J Cardiothorac Surg, January 1, 2010; 37(1): 30 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. B. Ratto, R. Costa, P. Maineri, A. Alloisio, P. Bruzzi, and B. Dozin Is there a subset of patients with preoperatively diagnosed N2 non-small cell lung cancer who might benefit from surgical resection? J. Thorac. Cardiovasc. Surg., October 1, 2009; 138(4): 849 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Gilbert and B. K. Hollenbeck Limitations of Lymph Node Counts as a Measure of Therapy J Natl Compr Canc Netw, January 1, 2009; 7(1): 58 - 61. [Abstract] [PDF]
|
|
|
|
|
|
M. Chida, M. Minowa, Y. Karube, S. Eba, Y. Okada, S. Miyoshi, and T. Kondo Worsened long-term outcomes and postoperative complications in octogenarians with lung cancer following mediastinal lymph-node dissection Interact CardioVasc Thorac Surg, January 1, 2009; 8(1): 89 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Mansour, E. A. Kochetkova, N. Santelmo, X. Ducrocq, E. Quoix, J.-M. Wihlm, and G. Massard Persistent N2 Disease After Induction Therapy Does Not Jeopardize Early and Medium Term Outcomes of Pneumonectomy Ann. Thorac. Surg., July 1, 2008; 86(1): 228 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. A. Melfi, M. Lucchi, F. Davini, A. Viti, G. Fontanini, L. Boldrini, G. Boni, and A. Mussi Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction Eur J Cardiothorac Surg, July 1, 2008; 34(1): 181 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhong, X. Yang, J. Bai, J. Yang, C. Manegold, and Y. Wu Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer Eur J Cardiothorac Surg, July 1, 2008; 34(1): 187 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Sienel, S. Dango, A. Kirschbaum, B. Cucuruz, W. Horth, C. Stremmel, and B. Passlick Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections Eur J Cardiothorac Surg, April 1, 2008; 33(4): 728 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-i. Watanabe, K. Suzuki, and H. Asamura Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Ann. Thorac. Surg., March 1, 2008; 85(3): 1026 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Szczesny, R. Slotwinski, B. Szczygiel, A. Stankiewicz, M. Zaleska, M. Kopacz, and A. Olesinska-Grodz Systematic mediastinal lymphadenectomy does not increase postoperative immune response after major lung resections Eur J Cardiothorac Surg, December 1, 2007; 32(6): 868 - 872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Whitson, S. S. Groth, and M. A. Maddaus Surgical Assessment and Intraoperative Management of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer Ann. Thorac. Surg., September 1, 2007; 84(3): 1059 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Robinson, J. C. Ruckdeschel, H. Wagner Jr, and C. W. Stevens Treatment of Non-small Cell Lung Cancer-Stage IIIA: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 243S - 265S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Muraoka, S. Akamine, T. Oka, T. Tagawa, A. Nakamura, T. Tsuchiya, T. Hayashi, and T. Nagayasu Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer Eur J Cardiothorac Surg, August 1, 2007; 32(2): 356 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Lee, C.-T. Wu, S.-W. Kuo, Y.-T. Tseng, and Y.-L. Chang Significance of Extranodal Extension of Regional Lymph Nodes in Surgically Resected Non-small Cell Lung Cancer Chest, April 1, 2007; 131(4): 993 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Welter, J. Jacobs, T. Krbek, C. Poettgen, and G. Stamatis Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer Eur J Cardiothorac Surg, February 1, 2007; 31(2): 167 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Lardinois, P. De Leyn, P. Van Schil, R. R. Porta, D. Waller, B. Passlick, M. Zielinski, K. Junker, E. A. Rendina, H.-B. Ris, et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer Eur J Cardiothorac Surg, November 1, 2006; 30(5): 787 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Kutlu and G. Olgac How does definition of 'complete resection' conduct surgical management of non-small cell lung cancer? Interact CardioVasc Thorac Surg, October 1, 2006; 5(5): 643 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Massard, X. Ducrocq, E. A. Kochetkova, V. A. Porhanov, and M. Riquet Sampling or node dissection for intraoperative staging of lung cancer: a multicentric cross-sectional study Eur J Cardiothorac Surg, July 1, 2006; 30(1): 164 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Casali, A. Stefani, E. Storelli, and U. Morandi Prognostic factors and survival after resection of lung metastases from epithelial tumours Interact CardioVasc Thorac Surg, June 1, 2006; 5(3): 317 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, T. Sakamoto, T. Yuki, T. Mimura, K. Miyoshi, and N. Tsubota Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non-Small Cell Lung Cancer Ann. Thorac. Surg., March 1, 2006; 81(3): 1028 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Pfannschmidt, J. Klode, T. Muley, H. Dienemann, and H. Hoffmann Nodal Involvement at the Time of Pulmonary Metastasectomy: Experiences in 245 Patients Ann. Thorac. Surg., February 1, 2006; 81(2): 448 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rami-Porta, M. Mateu-Navarro, J. Freixinet, M. de la Torre, A. Jose Torres-Garcia, Y.-W. Pun, A. Canto Armengod, and on behalf of the Bronchogenic Carcinoma Cooperativ Type of resection and prognosis in lung cancer. Experience of a multicentre study Eur J Cardiothorac Surg, October 1, 2005; 28(4): 622 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yoshimasu, S. Miyoshi, S. Oura, I. Hirai, Y. Kokawa, and Y. Okamura Limited mediastinal lymph node dissection for non-small cell lung cancer according to intraoperative histologic examinations J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 433 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nakano, K. Miyauchi, A. Horiuchi, and K. Kawachi Combined mediastinal node assessment by lymphadenectomy and intraoperative mediastinoscopy Interact CardioVasc Thorac Surg, August 1, 2005; 4(4): 374 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Lardinois, H. Suter, H. Hakki, V. Rousson, D. Betticher, and H.-B. Ris Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small Cell Lung Cancer Ann. Thorac. Surg., July 1, 2005; 80(1): 268 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-i. Watanabe, H. Asamura, K. Suzuki, and R. Tsuchiya Problems in Diagnosis and Surgical Management of Clinical N1 Non-small Cell Lung Cancer Ann. Thorac. Surg., May 1, 2005; 79(5): 1682 - 1685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Watanabe, T. Koyanagi, T. Obama, H. Ohsawa, T. Mawatari, N. Takahashi, Y. Ichimiya, and T. Abe Assessment of node dissection for clinical stage I primary lung cancer by VATS Eur J Cardiothorac Surg, May 1, 2005; 27(5): 745 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Patel and J. B. Shrager Which Patients with Stage III Non-Small Cell Lung Cancer Should Undergo Surgical Resection? Oncologist, May 1, 2005; 10(5): 335 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-i. Watanabe, H. Asamura, K. Suzuki, and R. Tsuchiya The new strategy of selective nodal dissection for lung cancer based on segment-specific patterns of nodal spread Interact CardioVasc Thorac Surg, April 1, 2005; 4(2): 106 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Doddoli, A. Aragon, F. Barlesi, B. Chetaille, S. Robitail, R. Giudicelli, P. Fuentes, and P. Thomas Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer? Eur J Cardiothorac Surg, April 1, 2005; 27(4): 680 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kuzdzal, M. Zielinski, B. Papla, A. Szlubowski, L. Hauer, T. Nabialek, W. Sosnicki, and J. Pankowski Transcervical extended mediastinal lymphadenectomy--the new operative technique and early results in lung cancer staging Eur J Cardiothorac Surg, March 1, 2005; 27(3): 384 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sakurai, H. Asamura, S.-i. Watanabe, K. Suzuki, and R. Tsuchiya Clinicopathologic features of peripheral squamous cell carcinoma of the lung Ann. Thorac. Surg., July 1, 2004; 78(1): 222 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Keller, M. G. Vangel, H. Wagner, J. H. Schiller, A. Herskovic, R. Komaki, R. S. Marks, M. C. Perry, R. B. Livingston, and D. H. Johnson Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 130 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Barnard, J. Dunning, G. Musleh, and N. Odom Is there a role for the use of radical lymph node dissection in the surgical management of resectable non-small cell lung cancer? Interact CardioVasc Thorac Surg, June 1, 2004; 3(2): 294 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Humphrey, S. Teutsch, and M. Johnson Lung Cancer Screening with Sputum Cytologic Examination, Chest Radiography, and Computed Tomography: An Update for the U.S. Preventive Services Task Force Ann Intern Med, May 4, 2004; 140(9): 740 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Wallace, J. Ravenel, M. I. Block, M. Fraig, G. Silvestri, S. Wildi, N. Schmulewitz, S. Varadarajulu, S. Roberts, B. J. Hoffman, et al. Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomography Ann. Thorac. Surg., May 1, 2004; 77(5): 1763 - 1768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Czerny, T. Fleck, A. Salat, D. Zimpfer, W. Klepetko, E. Wolner, and M. R. Mueller Sealing of the mediastinum with a local hemostyptic agent reduces chest tube duration after complete mediastinal lymph node dissection for stage I and II non-small cell lung carcinoma Ann. Thorac. Surg., March 1, 2004; 77(3): 1028 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Kern Sounding the Mediastinum Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1261 - 1262. [Full Text] [PDF]
|
|
|
|
 |
|
 C.K. Connolly, P.E.Y. Van Schil, R. Milroy, O. Braendli, and R.J. Prescott The approach to the surgical management of cancer in four European countries Eur. Respir. J., November 1, 2003; 22(5): 838 - 844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakagawa, Y. Minamiya, Y. Katayose, H. Saito, K. Taguchi, H. Imano, H. Watanabe, K. Enomoto, M. Sageshima, T. Ueda, et al. A novel method for sentinel lymph node mapping using magnetite in patients with non-small cell lung cancer J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 563 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gajra, N. Newman, G. P. Gamble, L. J. Kohman, and S. L. Graziano Effect of Number of Lymph Nodes Sampled on Outcome in Patients With Stage I Non-Small-Cell Lung Cancer J. Clin. Oncol., March 15, 2003; 21(6): 1029 - 1034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Marra, L. Hillejan, G. Zaboura, T. Fujimoto, D. Greschuchna, and G. Stamatis Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 543 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Myrdal, M. Lambe, G. Gustafsson, K. Nilsson, and E. Stahle Survival in primary lung cancer potentially cured by operation: influence of tumor stage and clinical characteristics Ann. Thorac. Surg., February 1, 2003; 75(2): 356 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. A. Melfi, A. Chella, G. F. Menconi, F. Givigliano, G. Boni, G. Mariani, P. Sbragia, and C. A. Angeletti Intraoperative radioguided sentinel lymph node biopsy in non-small cell lung cancer Eur J Cardiothorac Surg, February 1, 2003; 23(2): 214 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. Smythe Treatment of Stage I Non-small Cell Lung Carcinoma Chest, January 1, 2003; 123(2009): 181S - 187S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-i. Watanabe, M. Oda, Y. Tsunezuka, T. Go, Y. Ohta, and G. Watanabe Peripheral small-sized (2 cm or less) non-small cell lung cancer with mediastinal lymph node metastasis; clinicopathologic features and patterns of nodal spread Eur J Cardiothorac Surg, December 1, 2002; 22(6): 995 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Liptay Commentary on sentinel lymph node identification with technetium-99m tin colloid in non-small cell lung cancer J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 428 - 430. [Full Text] [PDF]
|
|
|
|
|
|
D. L. Miller, C. M. Rowland, C. Deschamps, M. S. Allen, V. F. Trastek, and P. C. Pairolero Surgical treatment of non-small cell lung cancer 1 cm or less in diameter Ann. Thorac. Surg., May 1, 2002; 73(5): 1545 - 1551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Ginsberg Invited commentary Ann. Thorac. Surg., May 1, 2002; 73(5): 1562 - 1562. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Liptay, S. C. Grondin, W. A. Fry, C. Pozdol, D. Carson, C. Knop, G. A. Masters, R. M. Perlman, and W. Watkin Intraoperative Sentinel Lymph Node Mapping in Non-Small-Cell Lung Cancer Improves Detection of Micrometastases J. Clin. Oncol., April 15, 2002; 20(8): 1984 - 1988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Ahrendt, S. C. Yang, L. Wu, C. M. Roig, P. Russell, W. H. Westra, J. Jen, M. V. Brock, R. F. Heitmiller, and D. Sidransky Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: Preliminary results of a prospective study J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 466 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Passlick, B. Kubuschock, W. Sienel, O. Thetter, K. Pantel, and J. R. Izbicki Mediastinal lymphadenectomy in non-small cell lung cancer: effectiveness in patients with or without nodal micrometastases -- results of a preliminary study Eur J Cardiothorac Surg, March 1, 2002; 21(3): 520 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-i. Watanabe, G. Ladas, and P. Goldstraw Inter-observer variability in systematic nodal dissection: comparison of European and Japanese nodal designation Ann. Thorac. Surg., January 1, 2002; 73(1): 245 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ohta, M. Oda, J. Wu, Y. Tsunezuka, M. Hiroshi, A. Nonomura, and G. Watanabe Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 900 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Machtay, J. H. Lee, J. B. Shrager, L. R. Kaiser, and E. Glatstein Risk of Death From Intercurrent Disease Is Not Excessively Increased by Modern Postoperative Radiotherapy for High-Risk Resected Non-Small-Cell Lung Carcinoma J. Clin. Oncol., October 1, 2001; 19(19): 3912 - 3917. [Abstract] [Full Text]
|
|
|
|
|
|
F. W. Grannis Jr A response to ""Clinical Trials in Lung Cancer: Truth, Justice, and the American Way"" Ann. Thorac. Surg., October 1, 2001; 72(4): 1438 - 1438. [Full Text] [PDF]
|
|
|
|
|
|
A. J. Poncelet, B. Weynand, F. Ferdin, A. R. Robert, P. H. Noirhomme, and on behalf of Groupe d'Oncologie Thoracique des Cli Bone marrow micrometastasis might not be a short-term predictor of survival in early stages non-small cell lung carcinoma Eur J Cardiothorac Surg, September 1, 2001; 20(3): 481 - 488. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
